emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Private Group led by Ardian / Bio 7

No EMAT : 65197
Announced Date : 05/06/2014
Type : SBO (Secondary Buy Out) ,Exit
Deal Value : Yes
Acquirer : Private Group led by Ardian

Target : Bio 7
Country : France
Sector of activity :
  • Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in Essonne in 1998, Bio 7 group is an operator of routine clinical pathology laboratories in Essonne, Seine et Marne and Yvelines, which are departments in the French Île-de-France region. >...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
30/05/2014 Virtus Health Sims Clinic (SIMS IVF) Ireland *** 65088
04/05/2012 Biotrin International NorDiag Molecular Diagnostic Business Norway *** 65007

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report